These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9777104)

  • 1. [Drugs of microbial origin for treatment of atherosclerosis].
    Bibikova MV; Bondareva NS
    Antibiot Khimioter; 1998; 43(8):34-9. PubMed ID: 9777104
    [No Abstract]   [Full Text] [Related]  

  • 2. New lipid lowering drugs and new effects of old drugs.
    Dujovne CA
    Curr Opin Lipidol; 1997 Dec; 8(6):362-8. PubMed ID: 9412777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and regression of atherosclerosis with drug therapy.
    Superko HR
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I40-7. PubMed ID: 2044258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 5. Statin policy and target populations: evidence-based or evidence-biased?
    Durrington P
    Curr Opin Lipidol; 2004 Aug; 15(4):381-6. PubMed ID: 15243209
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of cholesterol in the elderly: statins and beyond.
    LaRosa JC
    Curr Atheroscler Rep; 2014 Feb; 16(2):385. PubMed ID: 24395387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New targets and drugs for treatment of lipid metabolism disorders].
    Rau O; Zettl H; Popescu L; Steinhilber D; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2007; 36(2):142-8. PubMed ID: 17425000
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some aspects of pleiotropic effects of statins in internal medicine].
    Switalski M
    Pol Arch Med Wewn; 2003 Oct; 110(4):1173-9. PubMed ID: 14699676
    [No Abstract]   [Full Text] [Related]  

  • 9. Promising therapies for cholesterol reduction.
    Brown WV
    Manag Care; 2002 Sep; 11(9 Suppl):10-4. PubMed ID: 12369337
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart attacks: gone with the century?
    Brown MS; Goldstein JL
    Science; 1996 May; 272(5262):629. PubMed ID: 8614809
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatments for dyslipidemia associated with kidney disease].
    Hirano T; Yoshino G
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():748-52. PubMed ID: 11347167
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of mevinolin on experimental atherosclerosis in rabbits.
    Kritchevsky D; Tepper SA; Klurfeld DM
    Pharmacol Res Commun; 1981 Nov; 13(10):921-6. PubMed ID: 6918018
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardioprotective and other emerging effects of statins.
    Davignon J
    Int J Clin Pract Suppl; 2004 Oct; (143):49-57. PubMed ID: 16035396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nicotinic acid and the derivative].
    Ogaki S; Matsushima T
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():637-41. PubMed ID: 11347146
    [No Abstract]   [Full Text] [Related]  

  • 15. 150 kDa glycoprotein isolated from Solanum nigrum Linne enhances activities of detoxicant enzymes and lowers plasmic cholesterol in mouse.
    Lee SJ; Ko JH; Lim K; Lim KT
    Pharmacol Res; 2005 May; 51(5):399-408. PubMed ID: 15749454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of statin nephroprotective actions].
    Chmielewski M; Zdrojewski Z; Rutkowski B
    Przegl Lek; 2002; 59(7):519-22. PubMed ID: 12516241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination lipid-lowering therapy as first-line strategy in very high-risk patients.
    Ray KK; Reeskamp LF; Laufs U; Banach M; Mach F; Tokgözoğlu LS; Connolly DL; Gerrits AJ; Stroes ESG; Masana L; Kastelein JJP
    Eur Heart J; 2022 Feb; 43(8):830-833. PubMed ID: 34636884
    [No Abstract]   [Full Text] [Related]  

  • 18. [HMG-CoA reductase inhibitors].
    Yamamoto A
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():578-86. PubMed ID: 11347135
    [No Abstract]   [Full Text] [Related]  

  • 19. The resurgence of thyromimetics as lipid-modifying agents.
    Tancevski I; Eller P; Patsch JR; Ritsch A
    Curr Opin Investig Drugs; 2009 Sep; 10(9):912-8. PubMed ID: 19705333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.